InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Sayad Pierre Sargis. Director active across 1 company, notably Fennec Pharmaceuticals INC.. Aggregated, 1 filings have been recorded. Activity tracked since 31 May 2026. The latest transaction was filed on 31 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration